Theriva Biologics TOVX
NYSE TOVX
$0.20 -0.01 (-5.45%)
As of: Oct 21, 2026 · 3:59 PM EDT

Theriva Biologics (TOVX) Asset Utilization Ratio (2011 - 2026)

Updated

Theriva Biologics' (TOVX) Asset Utilization Ratio stood at -0.01 in Q2 2026.

Analysis

Theriva Biologics (TOVX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Starting with Q3 2011, Theriva Biologics' Asset Utilization Ratio history includes 4 quarters.

  • The Q2 2026 figure is the lowest quarterly Asset Utilization Ratio since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Theriva Biologics 9.11 Mn -37.25 Mn - -0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01
Mar 31, 2026 0.00
Dec 31, 2011 -0.03
Sep 30, 2011 0.11
API Access

Theriva Biologics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TOVX&period=max&api_key=YOUR_API_KEY